tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CMVLF Stock Latest News

Cellectis reports Q3 adjusted EPS 2c vs (22c) last year
The FlyCellectis reports Q3 adjusted EPS 2c vs (22c) last year
35m ago
CLLS
CMVLF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CMVLF Upcoming Earnings Report: What to Expect?
3d ago
Cellectis to present development update for eti-cel at ASH 2025
PremiumThe Fly
Cellectis to present development update for eti-cel at ASH 2025
4d ago
CLLS
Cellectis price target raised to $4 from $3 at Wells Fargo
PremiumThe Fly
Cellectis price target raised to $4 from $3 at Wells Fargo
18d ago
CLLS
Cellectis price target raised to $8 from $4 at Barclays
PremiumThe Fly
Cellectis price target raised to $8 from $4 at Barclays
22d ago
CLLS
Cellectis SA’s Promising Study on UCART20x22 for B-Cell Non-Hodgkin Lymphoma
PremiumCompany AnnouncementsCellectis SA’s Promising Study on UCART20x22 for B-Cell Non-Hodgkin Lymphoma
2M ago
CMVLF
Cellectis SA: Hold Rating Amid Upcoming Data Presentations and Financial Considerations
Premium
Ratings
Cellectis SA: Hold Rating Amid Upcoming Data Presentations and Financial Considerations
3M ago
CLLS
Cellectis S.A. Advances UCART123 Clinical Study in AML Treatment
Premium
Company Announcements
Cellectis S.A. Advances UCART123 Clinical Study in AML Treatment
3M ago
CLLS
Cellectis Reports Q2 2025 Results and Strategic Updates
PremiumCompany Announcements
Cellectis Reports Q2 2025 Results and Strategic Updates
3M ago
CMVLF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CMVLF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Cellectis files $200M mixed securities shelf
PremiumThe Fly
Cellectis files $200M mixed securities shelf
4M ago
CLLS
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
PremiumRatings
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
6M ago
CLLS
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
PremiumRatingsCellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
6M ago
CLLS
Cellectis price target lowered to $4 from $5 at Barclays
Premium
The Fly
Cellectis price target lowered to $4 from $5 at Barclays
6M ago
CLLS
Cellectis SA Reports Q1 2025 Financial Results
Premium
Company Announcements
Cellectis SA Reports Q1 2025 Financial Results
6M ago
Is CMVLF a Buy, Before Earnings?
PremiumPre-Earnings
Is CMVLF a Buy, Before Earnings?
6M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
8M ago
ALT
CLLS
Cellectis Reports 2024 Financial Results and Strategic Progress
PremiumCompany Announcements
Cellectis Reports 2024 Financial Results and Strategic Progress
8M ago
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
PremiumRatings
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
8M ago
CLLS
Cellectis Reports 2024 Financial Results and Strategic Advances in CAR T-Cell Therapies
PremiumCompany AnnouncementsCellectis Reports 2024 Financial Results and Strategic Advances in CAR T-Cell Therapies
8M ago
Cellectis Advances Clinical Programs and Strengthens AstraZeneca Partnership
Premium
Company Announcements
Cellectis Advances Clinical Programs and Strengthens AstraZeneca Partnership
8M ago
Cellectis reports Q4 EPS (64c) vs (17c) last year
Premium
The Fly
Cellectis reports Q4 EPS (64c) vs (17c) last year
8M ago
AZN
CLLS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >